These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19483489)

  • 1. Inappropriate conclusions from the use of botulinum toxin for the treatment of spasticity.
    Zakine B; Maisonobe P; Pickett AM
    Clin Neuropharmacol; 2009; 32(3):171; author reply 172-3. PubMed ID: 19483489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Botulinum toxin Type A. Indications and results].
    Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of botulinum toxin type A in children younger than 2 years.
    Pascual-Pascual SI; Pascual-Castroviejo I
    Eur J Paediatr Neurol; 2009 Nov; 13(6):511-5. PubMed ID: 19036619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose standardization of botulinum toxin.
    Van den Bergh PY; Lison DF
    Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920
    [No Abstract]   [Full Text] [Related]  

  • 5. How do we get better outcome with botulinum toxin in the treatment of children with spastic hemiplegia?
    Dai AI
    Eura Medicophys; 2007 Jun; 43(2):296-7; author reply 297. PubMed ID: 17589419
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
    Jeppesen LL; Dalager T; Meden P
    Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term safety of botulinum toxin type A.
    Naumann M; Moore AP
    Mov Disord; 2003 Sep; 18(9):1080-1. PubMed ID: 14502686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines for the treatment of child spasticity using botulinum toxin].
    Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
    Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type A botulin toxin.
    Prescrire Int; 2007 Jun; 16(89):106. PubMed ID: 17590906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of botulinum toxin].
    Jost WH
    Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacromial impingement syndrome as a consequence of botulinum therapy to the upper trapezii: a case report.
    Abbott Z; Richardson JK
    Arch Phys Med Rehabil; 2007 Jul; 88(7):947-9. PubMed ID: 17601479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botox: beyond cosmetic fixes. The procedure that revolutionized wrinkle treatment has myriad medical uses, many still experimental. What's the evidence?
    Harv Womens Health Watch; 2009 Sep; 17(1):1-3. PubMed ID: 19928628
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
    Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD
    Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
    Rivard PF; Nugent AC; Symons FJ
    Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications.
    Borodic G
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):11-6, v. PubMed ID: 17317551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.